Dr Michael Harris
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
15 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Germline BRCA1 pathogenic variants and T cell dysfunction
DOI: 10.1016/j.iotech.2026.1016012026
Journal article
Defensin-DNA Supramolecular Complexes as a New pH-Sensing Nanomaterial
DOI: 10.1002/agt2.703852026
Journal article
Parity and lactation induce T-cell-mediated breast cancer protection
DOI: 10.1038/s41586-025-09713-52026
Journal article
Motherhood’s immune legacy reshapes the breast for lasting cancer defence
DOI: 10.1016/j.iotech.2026.1015992024
Journal article
Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo
DOI: 10.1186/s12885-024-13088-72024
Journal article
The anti-cancer immune response in breast cancer: current and emerging biomarkers and treatments
DOI: 10.1016/j.trecan.2024.02.0082023
Research grants (international)
Virtual Cancer Prevention Centre
RECENT SCHOLARLY WORKS
2024
Journal article
Towards targeting the breast cancer immune microenvironment
DOI: 10.1038/s41568-024-00714-62022
Journal article
Recent and Ongoing Research into Metastatic Osteosarcoma Treatments
DOI: 10.3390/ijms230738172021
Journal article
Establishment and characterisation of metastatic extraskeletal ewing sarcoma mouse models
DOI: 10.21873/invivo.126042021
Journal article
The smac mimetic LCL161 targets established pulmonary osteosarcoma metastases in mice
DOI: 10.1007/s10585-021-10116-9